Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-24

Clinical Trial Update: Intra-rectal Botulinum Toxin Injection for Intractable Non-retentive Fecal Incontinence in Children - an Open Label Pilot Study [EARLY_Phase 1]

View source ↗

Summary

Open-label Phase 1 trial evaluating intra-rectal botulinum toxin injections for intractable non-retentive fecal incontinence in children; status is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OnabotulinumtoxinA (Botox) (Botulinum toxin type A)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Fecal Incontinence | EARLY_Phase 1 | Status: NOT_YET_RECRUITING